[ Price : $8.95]
The Alliance for Regenerative Medicine raises concerns about an FDA draft guidance on alternative manufacturing technologies.[ Price : $8.95]
FDA approves Bristol Myers Squibbs Opdivo (nivolumab) for combination use with cisplatin and gemcitabine for first-line treatment ...[ Price : $8.95]
Five House Republicans and one Democrat from Arizona and California call on FDA to add Valley Fever to the list of tropical diseas...[ Price : $8.95]
FDA classifies as Class 1 a Medtronic Neurology recall of its Duet External Drainage and Monitoring System due to the potential fo...[ Price : $8.95]
Federal Register notice: FDA makes available two International Council for Harmonization final guidances entitled Q2(R2) Validatio...[ Price : $8.95]
Federal Register notice: FDA renews its Gastrointestinal Drugs Advisory Committee for an additional two years beyond the charter e...[ Price : $8.95]
Ventec Life Systems recalls its VOCSN Patient Breathing Package due to a manufacturing issue that causes the bonded spiral wrap to...[ Price : $8.95]
FDA publishes the ICH Q14 guidance on analytical procedure development.